KR890011884A - 캠프토데신 유도체 - Google Patents

캠프토데신 유도체 Download PDF

Info

Publication number
KR890011884A
KR890011884A KR1019890000524A KR890000524A KR890011884A KR 890011884 A KR890011884 A KR 890011884A KR 1019890000524 A KR1019890000524 A KR 1019890000524A KR 890000524 A KR890000524 A KR 890000524A KR 890011884 A KR890011884 A KR 890011884A
Authority
KR
South Korea
Prior art keywords
group
hydroxyl
amino
hydrogen
lower alkyl
Prior art date
Application number
KR1019890000524A
Other languages
English (en)
Other versions
KR960007866B1 (ko
Inventor
다까시 야에가시
사토루 오까지마
세이고 사와다
겐이치로오 노가라
겐이치 데즈까
히로시 나가타
데루오 요코쿠라
타다시 미야사까
Original Assignee
구와하라 쥰
가부시끼 가이샤 야쿠루토 혼샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 구와하라 쥰, 가부시끼 가이샤 야쿠루토 혼샤 filed Critical 구와하라 쥰
Publication of KR890011884A publication Critical patent/KR890011884A/ko
Application granted granted Critical
Publication of KR960007866B1 publication Critical patent/KR960007866B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

내용 없음

Description

캠프토데신 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 일반식(Ⅰ)
    (식중에서 R1은 저급알킬기를 나타내고, R2는 수소원자, 아미노기, 수산기, 저급아실아미노기 또는 저급 알콕실기를 나타내며, R3은, 수소원자, 할로겐원자, 저급알킬기, 수산기 저급알콕실기, 니트로기, 아미노기, 시아노기 또는디 저급알킬아미노기를 나타내고, R4는 수소원자, 할로겐원자, 저급알킬기, 수산기, 저급알콕실기, 저급알킬티오기, 아미노기, 시아노기, 또는 디 저급알킬아미노기를 나타내며, R5는, 수소원자, 할로겐원자, 수산기, 또는 저급 알콕실기를 나타냄. 다만, R2, R3, R4및 R5가 동시에 수소원자인 경우는 없고, 또한, R2, R3, R4및 R5중의 어느 하나가 수산기 또는 저급 알콕실기인 경우에는 나머지 전부가 동시에 수소원자인 경우도 없다)로 나타내어지는 캠프토데신 유도체.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890000524A 1988-01-20 1989-01-19 캠프토데신 유도체 KR960007866B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP63008388A JPH0615547B2 (ja) 1988-01-20 1988-01-20 新規なカンプトテシン誘導体
JP8388 1988-01-20

Publications (2)

Publication Number Publication Date
KR890011884A true KR890011884A (ko) 1989-08-23
KR960007866B1 KR960007866B1 (ko) 1996-06-13

Family

ID=11691823

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890000524A KR960007866B1 (ko) 1988-01-20 1989-01-19 캠프토데신 유도체

Country Status (9)

Country Link
US (1) US5061800A (ko)
EP (1) EP0325247B1 (ko)
JP (1) JPH0615547B2 (ko)
KR (1) KR960007866B1 (ko)
AT (1) ATE89559T1 (ko)
CA (1) CA1332414C (ko)
DE (1) DE68906552T2 (ko)
ES (1) ES2056962T3 (ko)
GR (1) GR3007919T3 (ko)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939255A (en) * 1987-06-24 1990-07-03 Daiichi Pharmaceutical Co., Ltd. Hexa-cyclic camptothecin derivatives
EP0418099B1 (en) * 1989-09-15 2001-12-19 Research Triangle Institute Process of preparation of 10, 11-Methylenedioxy-20 (RS) camptothecin and 10, 11-methylenedioxy-20 (S) - camptothecin analog
US5552154A (en) * 1989-11-06 1996-09-03 The Stehlin Foundation For Cancer Research Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
JP2684104B2 (ja) * 1990-02-09 1997-12-03 株式会社ヤクルト本社 新規なカンプトテシン誘導体
HU213136B (en) * 1990-08-14 1997-02-28 Kyorin Seiyaku Kk Process for producing fluoroethyl camptothecin derivatives and pharmaceutical compositions containing them
DE69131775T2 (de) * 1990-09-28 2000-04-20 Smithkline Beecham Corp. Verfahren zur Herstellung wasserlöslicher Camptothecinanaloge, sowie die Verbindungen 10-Hydroxy-11-C(1-6)-alkoxycamptothecin
US5883255A (en) * 1990-10-31 1999-03-16 Smithkline Beecham Corporation Substituted indolizino 1,2-b!quinolinones
US5264579A (en) * 1990-12-20 1993-11-23 North Carolina State University D ring intermediates for the synthesis of camptothecin and camptothecin analogs
US5212317A (en) * 1990-12-20 1993-05-18 North Carolina State University Methods and intermediates for the assymmetric synthesis of camptothecin and camptothecin analogs
US5254690A (en) * 1990-12-20 1993-10-19 North Carolina State University Alkoxymethylpyridine d-ring intermediates useful for the synthesis of camptpthecin and camptothecin analogs
US5200524A (en) * 1990-12-20 1993-04-06 North Carolina State University Camptothecin intermediates and method of making same
US5162532A (en) * 1990-12-20 1992-11-10 North Carolina State University Intermediates and method of making camptothecin and camptothecin analogs
US5258516A (en) * 1990-12-20 1993-11-02 Nc State University Optically pure D,E ring intermediates useful for the synthesis of camptothecin and camptothecin analogs
US5315007A (en) * 1990-12-20 1994-05-24 North Carolina State University Process for making DE ring intermediates for the synthesis of camptothecin and camptothecin analogs
US6080751A (en) * 1992-01-14 2000-06-27 The Stehlin Foundation For Cancer Research Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof
US5459269A (en) * 1992-06-18 1995-10-17 North Carolina State University 14-halo-camptothecins
US5428166A (en) * 1992-06-18 1995-06-27 North Carolina State University Method of making asymmetric de ring intermediates for the synthesis of camptothecin and camptothecin analogs
US5391745A (en) * 1992-07-23 1995-02-21 Sloan-Kettering Institute For Cancer Research Methods of preparation of camptothecin analogs
US5446047A (en) * 1992-07-23 1995-08-29 Sloan-Kettering Institute For Cancer Research Camptothecin analogues
AP9300587A0 (en) * 1992-11-12 1995-05-05 Glaxo Inc Water soluble camptothecin derivatives.
WO1995003803A1 (en) * 1993-08-03 1995-02-09 Smithkline Beecham Corporation SUBSTITUTED FURO[3',4':6,7]INDOLIZINO[1,2-b]QUINOLINONES
US5475108A (en) * 1993-08-31 1995-12-12 North Carolina State University Camptothecin intermediates and method of making camptothecin and comptothecin analogs
US5447936A (en) * 1993-12-22 1995-09-05 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof
GB9402934D0 (en) * 1994-02-16 1994-04-06 Erba Carlo Spa Camptothecin derivatives and process for their preparation
US5468754A (en) * 1994-04-19 1995-11-21 Bionumerik Pharmaceuticals, Inc. 11,7 substituted camptothecin derivatives and formulations of 11,7 substituted camptothecin derivatives and methods for uses thereof
US5604233A (en) * 1994-04-28 1997-02-18 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of 7-ethyl camptothecin and methods for uses thereof
US5491237A (en) * 1994-05-03 1996-02-13 Glaxo Wellcome Inc. Intermediates in pharmaceutical camptothecin preparation
JPH0873461A (ja) * 1994-09-06 1996-03-19 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体、その製造法および抗腫瘍剤
US5496952A (en) * 1995-02-07 1996-03-05 North Carolina State University Method of making asymmetric DE ring intermediates for the synthesis of camptothecin and camptothecin analogs
GB9510716D0 (en) * 1995-05-26 1995-07-19 Pharmacia Spa Substituted camptothecin derivatives and process for their preparation
US5663177A (en) * 1995-05-31 1997-09-02 Smithkline Beecham Corporation Water soluble camptothecin analogs
US5726181A (en) * 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
US5942386A (en) * 1995-06-07 1999-08-24 Thomas Jefferson University Anti-fungal agents and methods of identifying and using the same
BR9711319B1 (pt) * 1996-08-19 2009-08-11 derivados de camptotecina altamente lipofìlicos.
SG88737A1 (en) * 1996-10-30 2002-05-21 Tanabe Seiyaku Co S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
US6559309B2 (en) 1996-11-01 2003-05-06 Osi Pharmaceuticals, Inc. Preparation of a camptothecin derivative by intramolecular cyclisation
US6169080B1 (en) * 1997-02-13 2001-01-02 Bionumerik Pharmaceuticals, Inc. Highly lipophilic camptothecin derivatives
ATE329903T1 (de) * 1997-02-14 2006-07-15 Bionumerik Pharmaceuticals Inc Hochgradig lipophile camptothecin-derivate
US6046209A (en) * 1997-05-27 2000-04-04 Smithkline Beecham Corporation Water soluble camptothecin analogs
JP4094710B2 (ja) 1997-11-06 2008-06-04 株式会社ヤクルト本社 新規なカンプトテシン誘導体
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
CZ298259B6 (cs) 2000-02-28 2007-08-08 Aventis Pharma S. A. Farmaceutická kombinace k lécení rakoviny obsahující CPT-11 a capecitabin
US6545010B2 (en) 2000-03-17 2003-04-08 Aventis Pharma S.A. Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer
US6548488B2 (en) 2000-03-17 2003-04-15 Aventis Pharma S.A. Composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer
AR027687A1 (es) * 2000-03-22 2003-04-09 Yakult Honsha Kk Procedimiento para preparar camptotecina
US6486320B2 (en) 2000-09-15 2002-11-26 Aventis Pharma S.A. Preparation of camptothecin and of its derivatives
EP1333820A2 (en) 2000-10-27 2003-08-13 Aventis Pharma S.A. A combination comprising camptothecin and a stilbene derivative for the treatment of cancer
JP2002255821A (ja) * 2001-03-06 2002-09-11 Yakult Honsha Co Ltd 抗癌剤耐性癌に対する治療剤
SK2242004A3 (en) * 2001-10-25 2004-11-03 Takeda Chemical Industries Ltd Quinoline compound
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
WO2004055020A1 (en) * 2002-12-16 2004-07-01 Council Of Scientific And Industrial Research Process for the direct preparation of 5-alkoxy and 5-acyloxy analogues of campthothecins or mappicene ketones
CZ299329B6 (cs) * 2003-08-26 2008-06-18 Pliva-Lachema A.S. Zpusob výroby 7-ethyl-10-[ 4-(1-piperidino)-1-piperidino]karbonyloxykamptothecinu
CZ299593B6 (cs) * 2003-12-16 2008-09-10 Pliva-Lachema A. S. Zpusob výroby 7-ethyl-10-hydroxykamptothecinu
WO2006069344A2 (en) 2004-12-22 2006-06-29 Rutgers, The State University Of New Jersey Controlled release hydrogels
CA2658015A1 (en) 2006-03-30 2007-10-11 Diatos S.A. Camptothecin-peptide conjugates and pharmaceutical compositions containing the same
US20140086975A1 (en) 2010-10-15 2014-03-27 Rutgers, The State University Of New Jersey Hydrogel formulation for dermal and ocular delivery
CN103509030A (zh) * 2012-06-18 2014-01-15 李雨亮 喜树碱类化合物及其制备和用途
LT3958977T (lt) * 2019-04-26 2023-12-27 Immunogen, Inc. Kamptotecino dariniai
CN110872305B (zh) * 2019-11-22 2021-05-04 浙江工业大学 一种氟化喜树碱药物衍生物及其制备与应用
WO2021173773A1 (en) * 2020-02-25 2021-09-02 Mediboston, Inc. Camptothecin derivatives and conjugates thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5839683A (ja) * 1981-09-04 1983-03-08 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
US4473692A (en) * 1981-09-04 1984-09-25 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
JPS58154584A (ja) * 1982-03-10 1983-09-14 Yakult Honsha Co Ltd ５位ヒドロキシ置換カンプトテシン誘導体の製造法
JPS6019790A (ja) * 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
JPS6185389A (ja) * 1984-10-03 1986-04-30 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
EP0220601B1 (en) * 1985-10-21 1991-12-11 Daiichi Seiyaku Co., Ltd. Pyranoindolizine derivatives and preparation process thereof

Also Published As

Publication number Publication date
EP0325247B1 (en) 1993-05-19
EP0325247A1 (en) 1989-07-26
ES2056962T3 (es) 1994-10-16
GR3007919T3 (ko) 1993-08-31
JPH0615547B2 (ja) 1994-03-02
DE68906552T2 (de) 1993-12-16
ATE89559T1 (de) 1993-06-15
DE68906552D1 (de) 1993-06-24
CA1332414C (en) 1994-10-11
KR960007866B1 (ko) 1996-06-13
US5061800A (en) 1991-10-29
JPH01186892A (ja) 1989-07-26

Similar Documents

Publication Publication Date Title
KR890011884A (ko) 캠프토데신 유도체
KR960704919A (ko) 신규인 펩티드 유도체 (novel peptide derivative)
KR890000489A (ko) 6 환 화합물
KR830007487A (ko) 심장질환치료제의 제조방법
KR920701162A (ko) 퀴놀린 유도체, 당해 유도체를 함유하는 항궤양제 및 당해 유도체의 제조방법
FI915783A (fi) N-jodipropargyloxikarbonyl- aminosyraesterar och derivat daerav samt deras anvaendning som antimikroba medel.
DK0390654T3 (da) Aminobenzensulfonsyrederivater
KR950702976A (ko) 벤조피란 및 벤족사진 유도체[benzopyran and benzoxazine derivatives]
DK0806413T3 (da) 2-substituerede viatmin D3-derivater
ES2043834T3 (es) Un procedimiento para preparar nuevos derivados de androsta-1,4-dien-3-ona sustituida en la posicion 17.
KR900003177A (ko) 테트라시클릭계 우울증 치료제
SE8902273D0 (sv) Indenoindole compounds i
DE69516605D1 (de) Camptothecin-Derivate, ihre Herstellung und Antitumormittel
KR900009640A (ko) 벤족 사제핀 유도체
KR890016006A (ko) 피롤 유도체
KR900000345A (ko) 1-할로 1-아졸일에탄유도체 및 이들을 함유하는 살균제
KR930023031A (ko) 아졸 유도체를 함유하는 항아로마타제제
KR830006316A (ko) 2,3,6,7-테트라하이드로티아졸로[3,2-a] 피리미딘 유도체의 제조방법
DE3889993D1 (de) 2'-Deoxy-5-fluorouridin-Derivate.
KR860006450A (ko) 5-클로로-1,3,4-티아디아졸-2-일옥시-아세트-아미드의 제조방법
SE8100743L (sv) Rifamycinderivat
KR900006295A (ko) 할로게노-4-메틸피라졸류 및 그의 제조방법
KR840004105A (ko) N,n- 치환된 아졸 카복스 아미드 유도체의 제조방법
TH3486EX (th) อนุพันธ์ของเฮเทอโรไซคลิคอามีด
KR880002867A (ko) 옥사디아진 화합물의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20040609

Year of fee payment: 9

LAPS Lapse due to unpaid annual fee